#Japan #AI Healthcare #Kagoshima #AMI Inc. #Yamato Fund

AMI Inc. Secures Investment for Innovative Healthcare Solutions

AMI Inc., a startup specializing in AI medical devices and telemedicine, has attained a significant milestone by securing investment from the Yamato Social Impact Investment Fund. This funding aims to bolster the development and integration of advanced healthcare technologies, focusing on implementing transformative solutions within the healthcare sector.

Located in Kagoshima, Japan, AMI Inc. strives to revolutionize the healthcare landscape by leveraging AI technology and sound engineering in its products, particularly the ‘Super Stethoscope’. Recently, the company was acknowledged at the Yamato Impact Investment Program's outcomes report by receiving the esteemed Ear Nashi Mountain Award. This recognition was given for providing effective solutions to regional healthcare issues, reinforcing AMI’s commitment to improving medical access and quality.

Funding Overview

The investment, part of a third-party allocation capital increase, reflects the confidence and support from notable partners:

• - Yamato Social Impact Investment Fund
• - Capital Medica Ventures Co., Ltd.
• - Nanto Capital Partners

This funding will serve as a cornerstone for AMI's expansion strategies, enhancing its healthcare solutions in the Yamato region and beyond.

Purpose of the Funding

The recently acquired capital will focus on several key initiatives, including:
1. Broader distribution and market expansion of AMI's FDA-approved ‘AMI-SSS01 Series’ heart sound analysis devices.
2. Strengthening the implementation of the ‘Cloud Super Diagnosis’ remote medical support system within regional healthcare networks.
3. Enhancing the AI technology behind heart disease screening mechanisms.
4. Promoting demonstration and implementation support projects in Nara Prefecture and nearby areas.

Comments from Partner Organizations

Takeshi Aoki, CEO of Capital Medica Ventures, expressed his enthusiasm, stating, “The Super Stethoscope is a beacon of hope amidst the global heart failure pandemic. The remarkable outcomes from our Nara demonstrations have inspired us to partner with AMI in their mission. We strongly believe in Mr. Ogawa’s vision and unwavering commitment.”

Similarly, Atsuki Sakai, CEO of Nanto Capital Partners, noted AMI's perseverance in addressing regional healthcare challenges through collaborative experiments with local medical institutions. He conveyed his admiration for AMI's dedication and the potential value creation for the community as they deepen their partnership moving forward.

Leadership Insight

Shinpei Ogawa, CEO of AMI, shared his appreciation for the investment from Yamato Social Impact Investment Fund. He emphasized the significance of the Ear Nashi Mountain Award as a symbol of AMI's goal to redefine auscultation and promote accessible healthcare for everyone, everywhere. With a strong focus on the integration of AI and acoustics, AMI continues to tackle real-world challenges within the medical sector.

Ogawa expressed confidence that this funding will be pivotal not only for addressing local healthcare issues but also for enabling AMI's ambitions for global outreach. He underscored their ongoing commitment to maximizing social impact alongside their new partners.

About AMI Inc.

Founded in November 2015, AMI Inc. is at the forefront of healthcare innovation, combining acoustics, electronics, and AI technologies to develop pioneering medical solutions. Their vision is to provide high-quality healthcare access to anyone, anywhere, through remote medical services and groundbreaking products.

Learn more about AMI Inc. and watch their promotional video here.

Company Overview

• - Name: AMI Inc.
• - CEO: Shinpei Ogawa
• - Established: November 2015
• - Headquarters: 2-13 Higashisenmachi, Kagoshima, Japan
• - Business Focus: Development of medical devices and provision of remote healthcare services.